Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer-Participation in Pathogenesis or a Possible Clinical Use?

Cells
Aleksandra Mielczarek-PalaczMarta Smycz-Kubańska

Abstract

Due to the ability to selectively induce apoptosis in cancer cells, the most interesting target for clinical research is the tumour necrosis factor ligand inducing apoptosis (TRAIL), which binds specific receptors, including osteoprotegerin (OPG). The aim of the study was to analyse the concentration of soluble TRAIL (sTRAIL) and OPG in the serum of women with serous or mucinous ovarian cancer, taking into account different levels of cancer histological differentiation. The group included 97 women with the diagnosed Cystadenocarcinoma papillare serosum IIIc and Cystadenocarcinoma mucinosum IIIc. Concentrations of parameters were measured by ELISA. Analysis of the obtained results showed a statistically significantly higher concentration of sTRAIL and OPG in the serum of women with ovarian serous and mucinous cancer compared to the control group (p < 0.0001). Statistical significance was found between sTRAIL and OPG concentration in G1 and G3 serous cancer (p < 0.01) and in OPG mucinous cancer between G1 and G3 (p < 0.01) and G2 and G3 (p < 0.01). An important role in the pathogenesis of ovarian cancer is played by disorders of the apoptosis process involving the sTRAIL/OPG system, which are associated with the histological type...Continue Reading

References

Apr 28, 2004·Vitamins and Hormones·Touraj Abdollahi
Nov 16, 2005·International Journal of Cancer. Journal International Du Cancer·Simon S CrossIngunn Holen
Dec 7, 2007·Disease Markers·Donna Badgwell, Robert C Bast
Sep 25, 2008·Nature Reviews. Cancer·Ricky W JohnstoneMark J Smyth
Mar 21, 2009·Cancer Letters·Gen Sheng Wu
Jul 20, 2010·Gynecologic Oncology·Kerri S BevisJ Michael Straughn
Sep 8, 2010·Expert Opinion on Therapeutic Targets·Junaid Abdulghani, Wafik S El-Deiry
Apr 15, 2011·International Journal of Oncology·Laura MercataliDino Amadori
Jan 12, 2012·Molecular Cancer Therapeutics·Christian T Hellwig, Markus Rehm
Jun 28, 2012·International Journal of Oncology·Ewelina SzliszkaWojciech Krol
Oct 18, 2012·Human Immunology·Aleksandra Mielczarek-PalaczGrzegorz Hauza
Nov 28, 2012·Archives of Medical Science : AMS·Aleksandra Mielczarek-PalaczJustyna Sikora
Jul 3, 2013·BioFactors·Eftychia Oikonomou, Alexander Pintzas
Oct 1, 2013·Trends in Molecular Medicine·Daniel W Stuckey, Khalid Shah
Jun 21, 2014·Cell Death and Differentiation·J LemkeH Walczak
Jul 9, 2014·Advances in Experimental Medicine and Biology·Simone Fulda
Jul 18, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Ammad Ahmad FarooqiHsueh-Wei Chang
Dec 17, 2015·Postȩpy higieny i medycyny doświadczalnej·Katarzyna Aleksandra Kujawa, Katarzyna Marta Lisowska
Apr 14, 2016·Oncotarget·Sudeshna Goswami, Neelam Sharma-Walia
May 26, 2017·Nature Reviews. Cancer·Silvia von KarstedtHenning Walczak
Mar 16, 2018·Cancer Metastasis Reviews·Xun YuanGen Sheng Wu
May 24, 2019·International Journal of Women's Health·Zohre MomenimovahedHamid Salehiniya
Aug 7, 2019·Bioorganic & Medicinal Chemistry Letters·George Nicolae Daniel IonCostin Ioan Popescu

❮ Previous
Next ❯

Citations

Jul 30, 2021·Frontiers in Cell and Developmental Biology·Ali HassanzadehMostafa Jarahian

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Statistica

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.